Navigation Links
CNBC Features MMJ International Holdings on FDA, DEA Approved Marijuana Studies
Date:7/12/2019

Ted Danson on CNBC will be hosting an interview of the MMJ International Holdings executives focusing on scientific research for the advancement of medical marijuana-based pharmaceuticals in an upcoming episode, scheduled to broadcast July 14, 2019 @ 1:30p.m. on CNBC. Check your local listings for more information.

With two investigational new drug applications already accepted by the FDA, MMJ International Holdings (MMJIH) is working to bring relief to patients suffering from Multiple Sclerosis and Huntington’s disease. This segment of advancements TV will focus on the science of medical cannabis and how our development of a pharmaceutical medicine of THC and cannabidiol, or CBD, is going to help people manage symptoms associated with Multiple Sclerosis, Huntington’s and other like neurological diseases.

“MMJ is excited to be part of this breakthrough episode of Advancements TV,” said CEO of MMJ International Holdings, Duane Boise. He continued, “We would like to commend the series on its vision and foresight in recognizing the need to educate audiences about the science of medical cannabis. MMJIH has always been an advocate for creating awareness about the value of marijuana-based pharmaceuticals. We believe that this industry is about to undergo a massive transformation and we are honored to be leader in the evolution of it.”

“MMJIH truly cares about helping people,” said Tim Moynahan, MMJIH Chairman “Using innovative technology, MMJ is helping to drastically cut drug development costs to obtain approval for an insurance reimbursable medicine. Patients are in need of a safe and effective marijuana-based pharmaceuticals to manage their unmet medical needs.”

About MMJIH:
MMJ International Holdings is dedicated to advancing the science of medical Cannabis. Having been awarded the FDA Orphan Designation, MMJIH is intent on bringing relief to patients around the world with its innovative and well FDA researched medical products. MMJ’s journey continues to prove the efficacy of cannabis as an FDA approved medicine while its unique scientific approach further distinguishes MMJ from others in the industry.

For more information, visit: http://www.mmjih.com.

Read the full story at https://www.prweb.com/releases/cnbc_features_mmj_international_holdings_on_fda_dea_approved_marijuana_studies/prweb16434134.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. NEPC’s February Education Interview of the Month Features Discussion of Teachers as Brand Ambassadors
2. Clearskincare Cites Flexible Reporting Features For Switch to Zenoti
3. "Information Matrix", with Laurence Fishburne, Features a New Piece on Preventative Medicine
4. Provista Launches One-Stop Web Destination For Industry News, Features And Information
5. Nature Biotechnology Features ReadCoor as a 2016 Leading Spinout
6. Data4Cures AI-Powered Biomedical Intelligence Cloud Features New Tools for Multidimensional Disease Mapping and Immune-Oncology Research
7. Synthetic Biologics Confirms Key Features of Pivotal Phase 2b/3 Trial of SYN-010 Pursuant to Consultations with FDA
8. CPhI SEA -- the leading pharma event in South East Asia - adds 6 new features
9. 2016 Continua Design Guidelines Include New Features For Simple Connectivity Of Personal Connected Health Devices
10. Excipient & Dosage Market Among Main Features of CPhI China 2016
11. CBS News Features Dr. Ashraf Hanna Describing How IV Ketamine is Successfully Treating Fibromyalgia Pain Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2020)... ... February 11, 2020 , ... FitFormula Wellness, makers of ... announce the addition of five new products to their family of ever-growing vitamins ... Classic Unflavored Calcium + Vitamin D, their supplements are simple, pure, gluten free, ...
(Date:2/10/2020)... ... February 11, 2020 , ... FDA Data Integrity, For ... Associates LLC and FDAnews, March 17-18, 2020, Doubletree Hotel Philadelphia Center City • ... Integrity: For Device and Pharma Firms, and Their Suppliers Workshop ends on Feb.18. ...
(Date:2/10/2020)... ... February 10, 2020 , ... Aspire ... EMSculpt treatments to patients. , EMSculpt is an FDA-approved treatment designed to ... abdomen, buttocks, thighs, calves, biceps, and triceps. The EMSculpt machine utilizes HIFEM® (High-Intensity ...
Breaking Medicine Technology:
(Date:2/13/2020)... ... , ... President Trump recently released his budget for fiscal ... to foreign affairs, global health, and global child vaccine programs. Overall, the budget ... programs by $3.1B, and significantly reduces funding for the global child immunization programs ...
(Date:2/11/2020)... ... 2020 , ... There are many reasons why Care to Care is a ... raises us above our competitors is our true Peer to Peer process. At Care ... of clinical experience. We understand that it is impossible to create criteria to cover ...
(Date:2/11/2020)... ... 2020 , ... The wait is finally over. The first wild card for the 2020 Tour ... been associating professional sports to a truly special project. , The group was originally formed ... athletes with diabetes. They decided to take on the ambitious mission to show that diabetes ...
(Date:2/11/2020)... ... February 11, 2020 , ... This week marks ... From Sourcing to Butchery, Mindful Meat Eating for the Modern Omnivore . Authored ... Publishers, this new version brings discussions of responsible meat production, consumption, and economics ...
(Date:2/10/2020)... , ... February 11, 2020 , ... R3 Medical Training ... March 11-12th, 2020 in Las Vegas. The training consists of thread lift placement on ... to register. , PDO thread lifts represent an excellent alternative currently for nonoperative facelift. ...
Breaking Medicine News(10 mins):